The pharmaceutical company Johnson & Johnson has temporarily stopped the production of its Covid-19 vaccine but says it is not expected to affect the vaccine’s availability in South Africa.

The New York Times reports that the shutdown of production at its plant in Leiden, the Netherlands, will last until March.

The Sunday Times reports that the Aspen plant in the Eastern Cape is still receiving the vaccine from Leiden and has no interruption in stock.